Should (Prophylactic) Medications Be Used for the Management of Death Rattle?

被引:5
|
作者
van Esch, Harriette Johanna [1 ,2 ,6 ,7 ]
Campbell, Margret L. [3 ]
Mori, Masanori [4 ]
Yamaguchi, Takayashi [5 ]
机构
[1] Erasmus MC, Dept Med Oncol, Canc Inst, Rotterdam, Netherlands
[2] Erasmus MC, Dept Publ Hlth, Canc Inst, Rotterdam, Netherlands
[3] Wayne State Univ, Coll Nursing, Detroit, MI USA
[4] Seirei Mikatahara Gen Hosp, Dept Palliat & Support Care, Hamamatsu, Japan
[5] Kobe Univ, Grad Sch Med, Dept Palliat Med, Kobe, Japan
[6] Erasmus MC, Dept Med Oncol, Canc Inst, Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands
[7] Erasmus MC, Dept Publ Hlth, Canc Inst, Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands
关键词
death rattle; randomised controlled trial; opinion; end-of -life care; RESPIRATORY-DISTRESS; SOUND; LIFE;
D O I
10.1016/j.jpainsymman.2023.06.017
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Death rattle is a common symptom in the dying phase and has impact on relatives and health care providers. One controversial topic regarding the management of death rattle in the dying phase is whether the symptom should be treated. In this "Controversies in Palliative Care" article, three expert clinicians independently answer this question. Specifically, each group provides a synopsis of the key studies that inform their thought processes, share practical advice on their clinical approach, and highlight the opportunities for future research. The three experts have different opinions on the assessment of death rattle. This seems to depend on the unknown burden of death rattle on the patient. Explanation of the symptom and reassurance could be sufficient. But considering the known burden on some of the relatives, there might be good reasons to use medication to relieve this symptom. Whether this treatment should be performed preventively or only when death rattle develops remains an matter of debate. Further scientific, clinical, and societal debate on the concept of a "good death" for relatives, the meaning of the symptom death rattle, and the impact of medication is needed. J Pain Symptom Manage 2023;66:e513-e517. (c) 2023 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:E513 / E517
页数:5
相关论文
共 50 条
  • [1] Should (Prophylactic) Medications Be Used for the Management of Death Rattle? (vol 66, pg e513, 2023)
    van Esch, Harriette Johanna
    Campbell, Margret L.
    Mori, Masanori
    Yamaguchi, Takashi
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2024, 68 (03) : 326 - 326
  • [2] Management of ''death rattle''
    Hughes, AC
    Wilcock, A
    Corcoran, R
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1996, 12 (05) : 271 - 272
  • [3] Preventing Death Rattle With Prophylactic Subcutaneous Scopolamine Butylbromide
    Lowe, Jared R.
    Hanson, Laura C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (13): : 1263 - 1265
  • [4] Should We Rescue Patients With the Death Rattle?
    Manthous, Constantine A.
    CRITICAL CARE MEDICINE, 2013, 41 (10) : 2430 - 2432
  • [5] Prophylactic Scopolamine Butylbromide and Death Rattle in Patients at the End of Life Reply
    Chen, Rong
    Wang, Jing Yan
    Lv, Kaiyang
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (03): : 285 - +
  • [6] Prophylactic scopolamine butylbromide reduced death rattle in patients in the dying phase
    Mechineni, Ashesha
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (03) : JC31 - JC31
  • [7] Why Standard Drug Treatments for the "Death Rattle" Should Be Discontinued
    Sarbey, Ben
    JOURNAL OF PALLIATIVE MEDICINE, 2022, 25 (02) : 180 - 180
  • [8] Death rattle
    Swaine, M
    DR DOBBS JOURNAL, 1999, 24 (04): : 128 - 128
  • [9] Death Rattle
    Pucciani, Donna
    STAND, 2020, 18 (03): : 73 - 73
  • [10] Glycopyrrolate and the Management of "Death Rattle" in Patients with Myasthenia Gravis
    Hindmarsh, Jonathan
    Everett, Paul
    Hindmarsh, Sharlene
    Lee, Mark
    Pickard, Jonathan
    JOURNAL OF PALLIATIVE MEDICINE, 2020, 23 (10) : 1408 - 1410